Exon BioSystems
|
Year Established:
2006 |
|
|
Website:
exonbio.com |
|
|
Company Type:
Small Business (1-10M TTM Revenue) |
|
|
Professional Associates:
BIOCOM |
ExonBio developed the SPIN technology that develops monoclonal antibodies from rabbits. Combined efficient antigen-specific plasma cell isolation and single cell technology. SPIN technology drastically increased the recombinant rabbit monoclonal antibody development efficiency.
Exonbio also provides large scale (gram level) antibody production and purification.
Exonbio also offers an extensive line of SARS-CoV-2 antibodies and antigens at the highest functional purity levels in order to help accelerate the research and development efforts by the life science community.
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.